• Aucun résultat trouvé

[PDF] Top 20 Cervical cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Has 10000 "Cervical cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up" found on our website. Below are the top 20 most common "Cervical cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up".

Cervical cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Cervical cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

... renal and liver function tests. MRI is superior to CT scan for tumor extension assessment and MRI is equal to CT scan for nodal ...scan and include pelvic and abdominal imaging ... Voir le document complet

2

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC)

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC)

... Minimum Clinical Recommendations for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) Incidence ...lung cancer in the European ... Voir le document complet

2

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of pancreatic cancer

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of pancreatic cancer

... Minimum Clinical Recommendations for diagnosis, treatment and follow-up of pancreatic cancer Incidence ...incidence and mortality of pancreatic ... Voir le document complet

2

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of soft tissue sarcomas

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of soft tissue sarcomas

... Minimum Clinical Recommendations for diagnosis, treatment and follow-up of soft tissue sarcomas Incidence ... Voir le document complet

2

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC)

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC)

... Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC) Incidence ...lung cancer in the European ... Voir le document complet

2

Ewing's sarcoma of the bone: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Ewing's sarcoma of the bone: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

... metastatic and recurrent disease Outside specific clinical trials, patients with metastatic disease ought to receive similar therapy to that given for localized disease, with appropriate local ... Voir le document complet

3

Ewing's sarcoma of the bone: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Ewing's sarcoma of the bone: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

... staging and risk assessment Before biopsy, the description of the local extent of the tumor requires radiographic and CT/MRI of the entire involved bone, including adjacent joints and soft ... Voir le document complet

2

Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†

Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†

... rates and used two concurrent arms with cisplatin–etoposide treatment found improved 5-year survival rates if the time between the first day of chemotherapy and the last day ... Voir le document complet

7

Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

... of cervical glands is not staged as a stage II ...of cervical stroma had been staged as a stage IIB high-risk tumour, where both pelvic RT and vaginal BT should be ...LVSI and/or negative ... Voir le document complet

5

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of chronic lymphocytic leukemia

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of chronic lymphocytic leukemia

... . The median survival at diagnosis varies between 2 and >10 years according to the initial stage of the disease. Two clinical staging systems are used. In Europe, the Binet sta- ging system is ... Voir le document complet

2

Locally recurrent or metastatic breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Locally recurrent or metastatic breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

... toxicity and better quality of life. Therefore, in the absence of the need for a rapid and significant response for symptom control or life-threatening disease, preference should be given to ... Voir le document complet

4

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of malignant glioma

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of malignant glioma

... Staging and risk assessment . Staging includes imaging of the brain, ideally with MRI. If repeat imaging is deemed necessary to determine residual disease, it should be done within 24 – 48 h after surgery. Lumbar ... Voir le document complet

2

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Hodgkin's disease

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Hodgkin's disease

... cycles and after the last cycle of chemo- or chemo-/radiotherapy by physical examination, laboratory analysis as above, and the same initially abnormal radio- graphic ...evaluated for active disease ... Voir le document complet

2

Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up †

Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up †

... rates and progression-free survival rates were achieved with EDP-M in comparison with ...therapy for ACC requiring cytotoxic therapy, and as the reference for new therapies (I, A; Figure 1 ... Voir le document complet

8

Melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

... necessary for this patient ...following treatment of metastases ultrasound of lymph nodes, CT or whole body PET/PET-CT scans may lead to an earlier diagnosis of regional or systemic ...specificity ... Voir le document complet

4

Acute myeloblastic leukemia in adult patients: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Acute myeloblastic leukemia in adult patients: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

... plan Treatment is divided into induction and consolidation ...Candidates for allogeneic stem-cell transplantation should be identified early during ...status and considerable comorbidity, as ... Voir le document complet

2

Acute myeloblastic leukemia in adult patients: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Acute myeloblastic leukemia in adult patients: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

... cytogenetics and molecular ...data and selected molecular ...t(8;21) and t(16;16) (including acute myelomonocytic leukemia with preponderance of eosinophil granulocytes) are considered as favorable, ... Voir le document complet

2

Acute myeloblastic leukemia in adult patients: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Acute myeloblastic leukemia in adult patients: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

... status and considerable co- morbidity, as well as elderly patients not eligible for curative treatment, should receive supportive ...AML treatment should be carried out within clinical ... Voir le document complet

2

ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of chronic myelogenous leukemia (CML)

ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of chronic myelogenous leukemia (CML)

... specific chromosomal translocation t(9;22), the Philadelphia chromosome, or its variants. Staging and risk assessment . The major risk is the transformation of the initial chronic into the blastic phase of the ... Voir le document complet

2

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

... muscles and serratus anterior muscle, but not the pectoralis ...a clinical–pathological entity characterized by diffuse erythema and edema (peau d’orange) involving a third or more of the skin of the ... Voir le document complet

13

Show all 10000 documents...